BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Eric Linsley to join panel at the MedTech Investing Conference in Minneapolis, MN
News | 05. 10. 2006
